相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokinetics
Youssef W. Naguib et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2021)
Can nanoparticles and nano-protein interactions bring a bright future for insulin delivery?
Ting Zhang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Thiophene Derivative-Loaded Nanoparticles Mediate Anticancer Activity Through the Inhibition of Kinases and Microtubule Assembly
Somaya A. Abdel-Rahman et al.
ADVANCED THERAPEUTICS (2021)
Continuous versus intermittent BRAF and MEK inhibition in patients withBRAF-mutated melanoma: a randomized phase 2 trial
Alain P. Algazi et al.
NATURE MEDICINE (2020)
Dosing of BRAF and MEK Inhibitors in Melanoma: No Point in Taking a Break
Jenny H. Lee et al.
CANCER CELL (2020)
Cyclohepta[b]thiophenes as Potential Antiproliferative Agents: Design, Synthesis, In Vitro, and In Vivo Anticancer Evaluation
Somaya A. Abdel-Rahman et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Dissolving Microneedles with Spatiotemporally controlled pulsatile release Nanosystem for Synergistic Chemo-photothermal Therapy of Melanoma
Wanbing Qin et al.
THERANOSTICS (2020)
Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
Antoni Ribas et al.
NATURE MEDICINE (2019)
Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles
Jie Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Formulation, Characterization And Evaluation Of Curcumin- Loaded PLGA- TPGS Nanoparticles For Liver Cancer Treatment
Xiao-ping Chen et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Synthetically lethal nanoparticles for treatment of endometrial cancer
Kareem Ebeid et al.
NATURE NANOTECHNOLOGY (2018)
Targeted drug delivery to melanoma
Qi Liu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib
Georgina Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Cisplatin-induced ERK1/2 activity promotes G1 to S phase progression which leads to chemoresistance of ovarian cancer cells
Michal Kielbik et al.
Oncotarget (2018)
In vivo distribution of zoledronic acid in a bisphosphonate-metal complex-based nanoparticle formulation synthesized by a reverse microemulsion method
Xu Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
An approach to suppress the evolution of resistance in BRAFV600E-mutant cancer
Yaohua Xue et al.
NATURE MEDICINE (2017)
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
G. V. Long et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice
Stefana Avram et al.
ONCOLOGY REPORTS (2017)
Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization, in vitro and in vivo studies
Raghuvir H. Gaonkar et al.
SCIENTIFIC REPORTS (2017)
The potential of protein-nanomaterial interaction for advanced drug delivery
Qiang Peng et al.
JOURNAL OF CONTROLLED RELEASE (2016)
The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC
Lei Li et al.
ONCOLOGY LETTERS (2016)
Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
Shih-Hsun Chen et al.
CANCER DISCOVERY (2016)
Propranolol induced G0/G1/S phase arrest and apoptosis in melanoma cells via AKT/MAPK pathway
Chengfang Zhou et al.
ONCOTARGET (2016)
Solid Lipid Nanoparticle Formulations of Docetaxel Prepared with High Melting Point Triglycerides: In Vitro and in Vivo Evaluation
Youssef Wahib Naguib et al.
MOLECULAR PHARMACEUTICS (2014)
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
James Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Role of integrated cancer nanomedicine in overcoming drug resistance
Arun K. Iyer et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Folate receptor targeted 17-allylamino-17-demethoxygeldanamycin (17-AAG) loaded polymeric nanoparticles for breast cancer
Vipin Saxena et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
A new understanding in the epidemiology of melanoma
Esther Erdei et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Phenotype and Genotype of Pancreatic Cancer Cell Lines
Emily L. Deer et al.
PANCREAS (2010)
Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy
Sudipta Basu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer
Aparna A. Kamat et al.
CLINICAL CANCER RESEARCH (2007)
Preventing paclitaxel-induced peripheral neuropathy: A phase II trial of vitamin E supplementation
Andreas A. Argyriou et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2006)
Peripheral neuropathy induced by paclitaxel: Recent insights and future perspectives
CD Scripture et al.
CURRENT NEUROPHARMACOLOGY (2006)
Cerulein-induced acute pancreatitis in the rat is significantly ameliorated by treatment with MEK1/2 inhibitors U0126 and PD98059
AP Clemons et al.
PANCREAS (2002)
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinase
HM Koo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Selective potentiation of paclitaxel (Taxol)-induced cell death by mitogen-activated protein kinase kinase inhibition in human cancer cell lines
HM McDaid et al.
MOLECULAR PHARMACOLOGY (2001)
Taxol-induced cell cycle arrest and apoptosis: dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition
GC Das et al.
CANCER LETTERS (2001)
Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated -: Up-regulation of p27Kip1
R Hoshino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
MEK inhibition enhances paclitaxel-induced tumor apoptosis
JP MacKeigan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
